Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.68 |
| ▸ | MAPT | P10636 | 8/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.64 |
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | CTSB | P07858 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | IDE | P14735 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7517180 | 0.89 | GAA (0.84) | GAAALDH1A1MAPTTDP1LMNA | |
| SCHEMBL9396792 | 0.89 | GAA (0.84) | GAAALDH1A1MAPTTDP1LMNA | |
| SCHEMBL7807230 | 0.85 | GAA (0.97) | GAAALDH1A1MAPTTDP1LMNA | |
| SCHEMBL2711990 | 0.84 | MAPT (0.77) | GAAALDH1A1MAPTTDP1LMNA | |
| SCHEMBL2103553 | 0.84 | ALDH1A1 (0.68) | GAAALDH1A1MAPTLMNAMAPK1 | |
| SCHEMBL29937693 | 0.84 | ALDH1A1 (0.68) | GAAALDH1A1MAPTLMNAMAPK1 | |
| SCHEMBL3738174 | 0.84 | GAA (1.00) | GAAALDH1A1MAPTTDP1LMNA | |
| SCHEMBL690222 | 0.83 | MAPT (0.63) | GAAALDH1A1MAPTTDP1LMNA | |
| SCHEMBL2712983 | 0.83 | MAPT (0.63) | GAAALDH1A1MAPTTDP1LMNA | |
| SCHEMBL2061743 | 0.83 | ALDH1A1 (0.66) | ALDH1A1MAPTLMNAMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010005914-A1 | OXIDATION DYES | ANDREAS J. BITTNER | 2001-07-05 | — | — | US | disclosed |
| EP-0912160-A2 | OXIDATION DYES | Hans Schwarzkopf GmbH & Co. KG (DE) | 1999-05-06 | — | — | EP | disclosed |
| WO-1998001106-A2 | OXIDATION DYES | HANS SCHWARZKOPF GMBH & CO. KG (DE) | 1998-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010005914-A1 | OXIDATION DYES | AOC1, CBR3, KRT18 | GAA 4430/4885ALDH1A1 26/4885MAPT 3633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.